Genscript Bio (01548.HK) announced that its subsidiary, Legend Biotech, is expected to report a preliminary adjusted net loss between $94.7 million and $0.11 billion for the six months ended June.
金斯瑞(01548.HK)附屬傳奇生物估計上半年虧損最多1.1億美元
Legend biotech, a subsidiary of King's Glory (01548.HK), is estimated to have a maximum loss of 0.11 billion US dollars in the first half of the year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.